Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Arcadia Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Acquisition
Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health
Details : Through the acquisition, Arcadia expands its portfolio of products by including Senokot®, Betadine®, Colace®, and SlowMag™ Mg. Senna glycoside, also known as sennoside or senna, is a medication used to treat constipation and empty the large intestin...
Brand Name : Senokot
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 05, 2023
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Arcadia Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Purdue Pharma’s Avrio Health Launches Two Senokot® Dietary Supplement Products
Details : Senokot (Sennoside) blueberry pomegranate flavor is a new flavor of senokot laxative* gummies for gentle overnight relief for occasional constipation.
Brand Name : Senokot
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 25, 2021
Lead Product(s) : Sennosides
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?